Author:
Huang Jianfei,Tang Qi,Wang Changjun,Yu Huixin,Feng Zhenqing,Zhu Jin
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Zhang, A., Sun, H. & Wang, X. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 57, 2072–2077 (2012).
2. El-Serag, H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118–1127 (2011).
3. Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245–1255 (2012).
4. Deckert, P. M. Current constructs and targets in clinical development for antibody-based cancer therapy. Curr. Drug. Targets 10, 158–175 (2009).
5. Leitha, T. Nuclear medicine: proof of principle for targeted drugs in diagnosis and therapy. Curr. Pharm. Des. 15, 173–187 (2009).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献